Use of tumor markers in testicular, prostate, colorectal, breast and ovarian cancers

被引：0
作者：
Duffy, Michael J.
Esteva, Francisco J.
Harbeck, Nadia
Hayes, Daniel F.
Molina, Rafael
机构：
来源：
ACTA BIOQUIMICA CLINICA LATINOAMERICANA | 2013年 / 47卷 / 04期
关键词：
PLASMINOGEN-ACTIVATOR UPA; MINIMUM CLINICAL RECOMMENDATIONS; INTERNATIONAL EXPERT CONSENSUS; LIGAND-BINDING ASSAY; ESTROGEN-RECEPTOR; GENE-EXPRESSION; PROGESTERONE-RECEPTOR; FOLLOW-UP; ADJUVANT CHEMOTHERAPY; PREDICTING RESPONSE;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：731 / 747
页数：17
相关论文
共 73 条
  • [1] Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
  • [2] Abraha RS, 2003, BREAST CANCER RES TR, V82, pS144
  • [3] [Anonymous], 2007, Clinical practice guidelines in oncology
  • [4] Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients
    Barnes, DM
    Harris, WH
    Smith, P
    Millis, RR
    Rubens, RD
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (09) : 1445 - 1451
  • [5] The clinical evaluation of HER-2 status: which test to use?
    Bartlett, J
    Mallon, E
    Cooke, T
    [J]. JOURNAL OF PATHOLOGY, 2003, 199 (04) : 411 - 417
  • [6] Evaluating HER2 amplification and overexpression in breast cancer
    Bartlett, JMS
    Going, JJ
    Mallon, EA
    Watters, AD
    Reeves, JR
    Stanton, P
    Richmond, J
    Donald, B
    Ferrier, R
    Cooke, TG
    [J]. JOURNAL OF PATHOLOGY, 2001, 195 (04) : 422 - 428
  • [7] Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 workshop
    Benraad, TJ
    GeurtsMoespot, J
    GrondahlHansen, J
    Schmitt, M
    Heuvel, JJTM
    deWitte, JH
    Foekens, JA
    Leake, RE
    Brunner, N
    Sweep, CGJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1371 - 1381
  • [8] Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Recommendation statement
    Berg, AO
    Allan, JD
    Calonge, N
    Frame, PS
    Gordis, L
    Gregory, KD
    Harris, R
    Johnson, MS
    Klein, JD
    Loveland-Cherry, C
    Moyer, VA
    Ockene, JK
    Petitti, DB
    Siu, AL
    Teutsch, SM
    Yawn, BP
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) : 355 - 361
  • [9] Facts and controversies in systemic treatment of metastatic breast cancer
    Bernard-Marty, C
    Cardoso, F
    Piccart, MJ
    [J]. ONCOLOGIST, 2004, 9 (06) : 617 - 632
  • [10] Birner P, 2001, CLIN CANCER RES, V7, P1669
12345678